Status report
Get it in writing
The official USPTO status record for XCELLDERMA, serial 99532907, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELLDERMASerial 99532907 · Principal Register
Dead · Refused
Owner: Regenerex Pharma, Inc.
Class 005 - Pharmaceuticals
Filed Dec 05, 2025
The record shows that XCELLDERMA is an abandoned application – the USPTO marked it “dead” after the applicant, Regenerex Pharma, Inc., failed to respond to an Office action, with the abandonment notice dated November 3 2026. The filing, made on December 5 2025, listed goods in International Class 5 covering medical and pharmaceutical preparations for wound care, including antiseptics, dressings and products aimed at healing or reducing odor in wounds, ulcers, burns and graft sites. Because the claim is limited to those pharmaceutical wound‑care items, a similar name used for unrelated products such as cosmetics, software or food would be farther from the scope shown here, though the record does not give the owner control over every possible use of the word. The prosecution history shows only the filing, an examiner assignment, a non‑final action in April 2026, an extension of time, and finally the abandonment; no oppositions, cancellations or court actions appear. I'd treat this as a meaningful concern if you plan a name in the same wound‑care pharmaceutical space.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.